Diabetes

Oramed hits midstage target in oral insulin trial

Bristol-Myers Squibb pulls out of Biocon oral insulin pact

Hua Medicine closes $50M round, looks to new diabetes target

Lilly, Boehringer to start heart failure trials for Jardiance